World Novel Drug Discovery Summit South Korea

Memo

Amongst established global biopharma powerhouses like the US and China, how does South Korea carve out its own innovation leadership position? Through active government investment into AI and in silico capabilities, combined with a uniquely collaborative culture for novelty, as seen through prominent partnerships from companies like 1st Biotherapeutics, Galux, Pharos iBio and SK Biopharmaceuticals, Korea is emerging as a distinct hub for drug discovery excellence to develop differentiated platforms that will deliver best-in-class, impactful breakthroughs. The World Novel Drug Discovery Summit South Korea is the first and only industry-led forum empowering K-Bio to accelerate innovation and strengthen its position as a globally recognised and competitive drug discovery powerhouse. Under the theme of accelerating future best-in-class platforms for next-generation modalities by integrating AI for smarter, faster and de-risked drug discovery, this inaugural forum will bring together 100+ K-Bio innovators, international pharma leaders and industry-renowned service providers to dive into cutting-edge technologies, proven drug discovery strategies, and collaborative networking opportunities to empower best-in-class Korean platforms and position K-Bio for global partnering and licensing opportunities. If you are working in drug discovery, this is where you need to be to generate new insights and connections to enable safer, faster and seamless drug discovery. URLs:Tickets: https://go.evvnt.com/3825072-2?pid=5569Brochure: https://go.evvnt.com/3825072-3?pid=5569 Date and Time: On Tue, 08 Dec 2026 08:00 - Thu, 10 Dec 2026 18:00 Venue Details: Grand Hyatt Incheon, 208 Yeongjonghaeannam-ro 321beon-gil, Jung-gu, Incheon, 22382, South Korea Category: Conferences | Science, Health and Medicine | Pharmaceuticals Prices:Drug developer Pricing - 3 Day Pass: USD 2199.00,Drug Developer Pricing - Conference Only: USD 1799.00,Academic Pricing - 3 Day Pass: USD 1899.00,Academic Pricing - Conference Only: USD 1599.00,Service Provider Pricing - 3 Day Pass: USD 1599.00,Service Provider Pricing - Conference Only: USD 3849.00 Speakers: Hanjo Kim, AI Drug Discovery Consultant, Zifo, Kyungsu Kim, Assistant Professor, Seoul National University, Daeseung Lee, Co-Founder and Chief Executive Officer, Portrai, Doo Young Jung, Founder and Chief Executive Officer, Pinotbio, Jihoon Kang, Co-Chief Executive Officer, ONCOCROSS, Hyun Mog Kim, Research Associate, Korea University, Haemin Chon, Vice President and Head, Convergence R and D Center, Hanmi Pharm, Namshik Han, Chief Technology Officer, CardiaTec, Wonil Kim, Chief Scientific Officer, Aston Sci, Sun Kim, Chief Executive Officer, AIGENDRUG, Jaewoo Kang, Founder and Chief Executive Officer, AIGEN Sciences, Vanessa Braunstein, Senior Director, TuneLab AI Drug Discovery Platform Ecosystem Growth, Eli Lilly and Co., Daniel Dai, Scientific Manager, Sanofi, Shan Chen, Senior Director, AIDD, Innovent Biologics, Chunhui Xu, Lead, AI4Glue platform, Degron Therapeutics